Metabologenomic assessment of biosynthetic capabilities in the genus Salinibacterium: untapped bioactive chemistry produced by marine strain AL4.1 isolated in the Chilean Patagonia

Antimicrobial resistance represents one of the most critical global public health challenges. Increasing evidence suggests that rare actinomycetes can harbour novel biosynthetic diversity to produce antimicrobial compounds. This work explores the capabilities for the biosynthesis of antimicrobial natural products of Salinibacterium sp. AL4.1, in contrast with those of Salinibacterium sp. VpJ6, through a comparative metabologenomic approach. Comparative bioactivity tests using both Salinibacterium strains AL4.1 and VpJ6 revealed antimicrobial bioactivity of crude extracts from strain AL4.1 against Staphylococcus aureus . Liquid chromatography coupled with tandem mass spectrometry was performed on the tested samples, allowing for metabolite dereplication as well as identification of bioactivity-associated features. This revealed the presence of potential aromatic polyketides structurally related to known bioactive compounds such as phloretin, for which bacterial production had not been reported to date, as well as other potentially novel alkaloids and peptides. The genomes of both strains were sequenced and mined for their biosynthetic capabilities and further compared to those of other Salinibacterium strains with available genomic data. Phylogenomic studies suggested that both strains AL4.1 and VpJ6 could represent potentially new species. A mainly phylogeny-dependent distribution of biosynthetic gene clusters (BGCs) was observed, emphasizing the presence of a widely distributed type III polyketide synthase BGC, which could be linked to the bioactive compounds. These results suggest that Salinibacterium sp. AL4.1 can produce novel bioactive natural products, and the genus Salinibacterium holds relevant and underexplored biosynthetic potential.

Authors

Institutions

Publication Details

Journal
Microbial Genomics
Published
2026-11-18
DOI
https://doi.org/10.1099/mgen.0.001891
Primary Topic
Microbial Natural Products and Biosynthesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Metabologenomic assessment of biosynthetic capabilities in the genus Salinibacterium: untapped bioactive chemistry produced by marine strain AL4.1 isolated in the Chilean Patagonia

Valentina González, Fernanda P. Claverías, Beatriz Cámara, Néstor Serna-Cardona et al.
2 links
Microbial Genomics
Microbial Natural Products and Biosynthesis
article

Metabologenomic assessment of biosynthetic capabilities in the genus Salinibacterium: untapped bioactive chemistry produced by marine strain AL4.1 isolated in the Chilean Patagonia

Valentina González, Fernanda P. Claverías, Beatriz Cámara, Néstor Serna-Cardona, Jonathan Parra, Eduardo Sánchez-Carvajal, Neri Vargas, Thomas Dacal-Barahona, Melissa González-Sanabria
article en

Abstract

Antimicrobial resistance represents one of the most critical global public health challenges. Increasing evidence suggests that rare actinomycetes can harbour novel biosynthetic diversity to produce antimicrobial compounds. This work explores the capabilities for the biosynthesis of antimicrobial natural products of Salinibacterium sp. AL4.1, in contrast with those of Salinibacterium sp. VpJ6, through a comparative metabologenomic approach. Comparative bioactivity tests using both Salinibacterium strains AL4.1 and VpJ6 revealed antimicrobial bioactivity of crude extracts from strain AL4.1 against Staphylococcus aureus . Liquid chromatography coupled with tandem mass spectrometry was performed on the tested samples, allowing for metabolite dereplication as well as identification of bioactivity-associated features. This revealed the presence of potential aromatic polyketides structurally related to known bioactive compounds such as phloretin, for which bacterial production had not been reported to date, as well as other potentially novel alkaloids and peptides. The genomes of both strains were sequenced and mined for their biosynthetic capabilities and further compared to those of other Salinibacterium strains with available genomic data. Phylogenomic studies suggested that both strains AL4.1 and VpJ6 could represent potentially new species. A mainly phylogeny-dependent distribution of biosynthetic gene clusters (BGCs) was observed, emphasizing the presence of a widely distributed type III polyketide synthase BGC, which could be linked to the bioactive compounds. These results suggest that Salinibacterium sp. AL4.1 can produce novel bioactive natural products, and the genus Salinibacterium holds relevant and underexplored biosynthetic potential.

Microbial GenomicsVol. 12(11)
Universidad de Costa Rica (CR), Consejo Nacional de Rectores (CR), Federico Santa María Technical University (CL)
Agencia Nacional de Investigación y Desarrollo, Vicerrectoría de Investigación, Universidad de Costa Rica
Microbial Natural Products and Biosynthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon